Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000354885 | SCV000396355 | uncertain significance | Combined oxidative phosphorylation deficiency | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001582957 | SCV001820345 | likely benign | not provided | 2019-02-11 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001582957 | SCV002251585 | uncertain significance | not provided | 2022-08-16 | criteria provided, single submitter | clinical testing | This sequence change falls in intron 9 of the TUFM gene. It does not directly change the encoded amino acid sequence of the TUFM protein. It affects a nucleotide within the consensus splice site. This variant is present in population databases (rs376169369, gnomAD 0.05%). This variant has not been reported in the literature in individuals affected with TUFM-related conditions. ClinVar contains an entry for this variant (Variation ID: 318743). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |